We've detected that you don't have the required Flash player to view our Web site.
Click here to download the latest Flash player.


OPTIMIZERx Files S-1 Registration Statement and Prepares to List NASDAQ

Phantom Fiber Time Signs a Multi-Year Contract With Mahjong Time

Beacon Equity Research Issues "Speculative Buy" rating for Phantom Fiber

Phantom Fiber Signs MulitYear Contract with Scientific Games

OPTIMIZERx to Partner with WPP Group's Sudler & Hennessey

OPTIMIZERx Receives $3.5M Funding to Support Growth

OPTIMIZERx to File Registration Statement

OPTIMIZERx Begins Audit of Financial Statements

Naturade Quarterly Report: Form 10Q

Phantom Fiber Quarterly Report: Form 10Q

GTX Corp and Phantom Fiber Sign Joint Venture Letter of Intent to Pursue Multi-Billion Dollar Geo Specific Mobile App Market

Phantom Fiber Completes Integrated GTS Mobile Platform for FX Solutions

Phantom Fiber to build integrated wireless solution for MyMedicalRecords.com.au

Phantom Fiber Retains First Capital Investors for Capital Markets Advisory and Investor Relations

OPTIMIZERx, Cegedim Dendrite Partner to Ensure Patients Stay on Their Medications

OPTIMIZERx Issues Letter to Shareholders

OPTIMIZERx Retains First Capital Investors for Investor Relations

Redux Holdings Featured in Los Angeles Business Journal

OPTIMIZERx Files Form S-1 with SEC & Prepares to List on NASDAQ

Rochester, MI - November 11, 2008 - OPTIMIZERx Corporation (OTCPK: OPRX) today announced that on Monday November 10, 2008, the Company filed a Form S-1 Registration Statement with the United States Securities Exchange Commission.

David Harrell, CEO of OPTIMIZERx, commented, "The filing of our Form S-1 is simply the next step in providing transparency and accountability to our shareholders. When we completed our reverse merger in the spring, we committed to our shareholders that we would work diligently to become a reporting company. After we receive notice from the regulators that our registration statement is effective, and upon meeting the various listing requirements, our goal is to list the trading of our stock with NASDAQ."

About OPTIMIZERx Corporation

OPTIMIZERx provides unique platforms to help patients better afford and comply with their medicines therapies and healthcare products, while offering pharmaceutical and healthcare companies effective methods to expand patient awareness, access and adherence to their brands. The Company's consumer website, www.OPTIMIZERx.com, and its permanent subscriber base, continues to grow each month and is quickly becoming the preferred way to access branded prescription savings and support programs. Additionally, OPTIMIZERx has integrated and developed peripheral offerings, including OFFERx™ offer management system and the ADHERxE™ platform to allow more brands to participate in promoting a new trial or co-pay program. For additional information on OPTIMIZERx, including an investor fact sheet, see www.firstcapitalinvestors.com.

'SAFE HARBOR'

This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:

Investor Relations

First Capital Investors, Inc.
www.firstcapitalinvestors.com
321-221-2910

Source: OPTIMIZERx Corporation

HOME   |   OUR CLIENTS   |   OUR SERVICES   |   MULTIMEDIA   |   RESEARCH   |   NEWS / PRESS   |   ABOUT US   |   CONTACT US
First Capital Investors, Inc. © 2008 -- Disclaimer Notice -- site by Everdez